Literature DB >> 19158830

miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities.

M Mraz, K Malinova, J Kotaskova, S Pavlova, B Tichy, J Malcikova, K Stano Kozubik, J Smardova, Y Brychtova, M Doubek, M Trbusek, J Mayer, S Pospisilova.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19158830     DOI： 10.1038/leu.2008.377

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  64 in total

Review 1.  Implication of microRNAs in drug resistance for designing novel cancer therapy.

Authors:  Fazlul H Sarkar; Yiwei Li; Zhiwei Wang; Dejuan Kong; Shadan Ali
Journal:  Drug Resist Updat       Date:  2010-03-17       Impact factor: 18.500

Review 2.  The role of TP53 network in the pathogenesis of chronic lymphocytic leukemia.

Authors:  Cheng Wang; Xin Wang
Journal:  Int J Clin Exp Pathol       Date:  2013-06-15

3.  Epigenetic regulation of WNT signaling in chronic lymphocytic leukemia.

Authors:  Lynda B Bennett; Kristen H Taylor; Gerald L Arthur; Farahnaz B Rahmatpanah; Sam I Hooshmand; Charles W Caldwell
Journal:  Epigenomics       Date:  2010-02-01       Impact factor: 4.778

Review 4.  Noncoding RNA and colorectal cancer: its epigenetic role.

Authors:  Yoshiaki Kita; Keiichi Yonemori; Yusaku Osako; Kenji Baba; Shinichiro Mori; Kosei Maemura; Shoji Natsugoe
Journal:  J Hum Genet       Date:  2016-06-09       Impact factor: 3.172

5.  Nutlin-3 differentially modulates miRNA34a and miRNA181 versus miR26a and miR155 in p53 proficient and p53 deficient B chronic lymphocytic leukemia (B-CLL) samples.

Authors:  Maria Grazia di Iasio; Riccardo Addobbati; Oriano Radillo; Rebecca Voltan
Journal:  Invest New Drugs       Date:  2011-05-31       Impact factor: 3.850

6.  microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.

Authors:  Jian-Jun Zhao; Jianhong Lin; Tint Lwin; Hua Yang; Jianping Guo; William Kong; Sophie Dessureault; Lynn C Moscinski; Dorna Rezania; William S Dalton; Eduardo Sotomayor; Jianguo Tao; Jin Q Cheng
Journal:  Blood       Date:  2010-01-19       Impact factor: 22.113

7.  MicroRNA-182-5p targets a network of genes involved in DNA repair.

Authors:  Keerthana Krishnan; Anita L Steptoe; Hilary C Martin; Shivangi Wani; Katia Nones; Nic Waddell; Mythily Mariasegaram; Peter T Simpson; Sunil R Lakhani; Brian Gabrielli; Alexander Vlassov; Nicole Cloonan; Sean M Grimmond
Journal:  RNA       Date:  2012-12-18       Impact factor: 4.942

Review 8.  The tumor-suppressive and potential therapeutic functions of miR-34a in epithelial carcinomas.

Authors:  Brian D Adams; Christine Parsons; Frank J Slack
Journal:  Expert Opin Ther Targets       Date:  2015-12-11       Impact factor: 6.902

9.  Expression level of human miR-34a correlates with glioma grade and prognosis.

Authors:  Haifeng Gao; Hongyang Zhao; Wei Xiang
Journal:  J Neurooncol       Date:  2013-03-26       Impact factor: 4.130

10.  PKCalpha mediated induction of miR-101 in human hepatoma HepG2 cells.

Authors:  Chao-Wei Chiang; Yi Huang; Ka-Wai Leong; Lih-Chyang Chen; Hua-Chien Chen; Shu-Jen Chen; Chen-Kung Chou
Journal:  J Biomed Sci       Date:  2010-05-06       Impact factor: 8.410
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.